UBS O'Connor’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History
Bought
Maintained
Sold
Other funds holding PEPL
PAMP
RCM
SCM
RCM
SIM
CSS
ACM
UBS O'Connor's PEPL Position: Q4 2022 in Review
UBS O'Connor sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q4 2022, closing a stake of 238,623 shares — an estimated $2.38M sold.
UBS O'Connor first reported a position in PEPL in Q4 2021 and held it in 3 quarters. The position peaked at $2.62M in Q2 2022. 43 funds tracked by Wall St. Rank hold PEPL as of Q4 2022.
- UBS O'Connor reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
- UBS O'Connor sold 238,623 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q4 2022, an estimated $2.38M.
- UBS O'Connor first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 3 quarters.
- UBS O'Connor's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $2.62M in Q2 2022.
- 43 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q4 2022.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.